Keratins and skin disease

Cell and Tissue Research

Volumn 360, Issue 3, 2015, Pages 583-589

  Knöbel, Maria ^a   O’Toole, Edel A ^a   Smith, Frances J D ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Epidermolysis bullosa simplex; Genetics; Ichthyosis; Keratin; Pachyonychia; siRNA

Indexed keywords

CYTOKERATIN 1; CYTOKERATIN 10; CYTOKERATIN 14; CYTOKERATIN 16; CYTOKERATIN 17; CYTOKERATIN 2; CYTOKERATIN 5; CYTOKERATIN 6; CYTOKERATIN 71; CYTOKERATIN 74; CYTOKERATIN 75; CYTOKERATIN 81; CYTOKERATIN 83; CYTOKERATIN 86; KERATIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; BASAL CELL CARCINOMA; CONGENITAL PACHYONYCHIA; CONGENITAL RETICULAR ICHTHYOSIFORM ERYTHRODERMA; CURTH MACKIN TYPE; CYCLIC ICHTHYOSIS; DERMATOPATHIA PIGMENTOSA RETICULARIS; DIFFUSE NONEPIDERMOLYTIC PALMOPLANTAR KERATODERMA; DOWLING DEGOS DISEASE; ECTODERMAL DYSPLASIA; EPIDERMOLYSIS BULLOSA SIMPLEX; EPIDERMOLYTIC HYPERKERATOSIS; EPIDERMOLYTIC ICHTHYOSIS; EPIDERMOLYTIC PALMOPLANTAR KERATODERMA; HUMAN; ICHTHYOSIS HYSTRIX; MIGRATORY CIRCINATE ERYTHEMA; MONILETHRIX; NAEGELI FRANCESCHETTI JADASSOHN SYNDROME; PRIORITY JOURNAL; PROTEIN PROCESSING; PSEUDOFOLLICULITIS BARBAE; RNA INTERFERENCE; SKIN DISEASE; STEATOCYSTOMA MULTIPLEX; STRIATE PALMOPLANTAR KERATODERMA; SUPERFICIAL EPIDERMOLYTIC ICHTHYOSIS; TYLOSIS; WOOLLY HAIR; ANIMAL; BIOMECHANICS; GENETICS; HAIR DISEASES; METABOLISM; MUTATION; PATHOLOGY; SKIN DISEASES;

ANIMALS; BIOMECHANICAL PHENOMENA; HAIR DISEASES; HUMANS; KERATINS; MUTATION; SKIN DISEASES;

EID: 84930271250     PISSN: 0302766X     EISSN: 14320878     Source Type: Journal    
DOI: 10.1007/s00441-014-2105-4     Document Type: Article

References (49)

1. Alam H, Gangadaran P, Bhate AV et al (2011) Loss of keratin 8 phosphorylation leads to increased tumor progression and correlates with clinico-pathological parameters of OSCC patients. PLoS ONE 6:e27767. doi:10.1371/journal.pone.0027767
2. Arin MJ (2009) The molecular basis of human keratin disorders. Hum Genet 125:355–73. doi:10.1007/s00439-009-0646-5
3. Atkinson SD, McGilligan VE, Liao H et al (2011) Development of allele-specific therapeutic siRNA for keratin 5 mutations in epidermolysis bullosa simplex. J Invest Dermatol 131:2079–86. doi:10.1038/jid.2011.169
4. Bär J, Kumar V, Roth W et al (2014) Skin fragility and impaired desmosomal adhesion in mice lacking all keratins. J Invest Dermatol 134:1012–22. doi:10.1038/jid.2013.416
5. Bonifas JM, Rothman AL, Epstein EH (1991) Epidermolysis bullosa simplex: evidence in two families for keratin gene abnormalities. Science 254:1202–5
6. Busch T, Armacki M, Eiseler T et al (2012) Keratin 8 phosphorylation regulates keratin reorganization and migration of epithelial tumor cells. J Cell Sci 125:2148–59. doi:10.1242/jcs.080127
7. Chamcheu JC, Siddiqui IA, Syed DN et al (2011) Keratin gene mutations in disorders of human skin and its appendages. Arch Biochem Biophys 508:123–37. doi:10.1016/j.abb.2010.12.019
8. Chamcheu JC, Wood GS, Siddiqui IA et al (2012) Progress towards genetic and pharmacological therapies for keratin genodermatoses: current perspective and future promise. Exp Dermatol 21:481–9. doi:10.1111/j.1600-0625.2012.01534.x
9. Choate KA, Lu Y, Zhou J et al (2010) Mitotic recombination in patients with ichthyosis causes reversion of dominant mutations in KRT10. Science 330:94–7
10. Chou CF, Smith AJ, Omary MB (1992) Characterization and dynamics of O-linked glycosylation of human cytokeratin 8 and 18. J Biol Chem 267:3901–6
11. Chung B-M, Rotty JD, Coulombe PA (2013) Networking galore: intermediate filaments and cell migration. Curr Opin Cell Biol 25:600–12. doi:10.1016/j.ceb.2013.06.008
12. Coulombe PA, Hutton ME, Letai A et al (1991) Point mutations in human keratin 14 genes of epidermolysis bullosa simplex patients: genetic and functional analyses. Cell 66:1301–11
13. Covello SP, Smith FJ, Sillevis Smitt JH et al (1998) Keratin 17 mutations cause either steatocystoma multiplex or pachyonychia congenita type 2. Br J Dermatol 139:475–80
14. Depianto D, Kerns ML, Dlugosz AA, Coulombe PA (2010) Keratin 17 promotes epithelial proliferation and tumor growth by polarizing the immune response in skin. Nat Genet 42:910–4. doi:10.1038/ng.665
15. Dinkova-Kostova AT, Fahey JW, Wade KL et al (2007) Induction of the phase 2 response in mouse and human skin by sulforaphane-containing broccoli sprout extracts. Cancer Epidemiol Biomarkers Prev 16:847–51. doi:10.1158/1055-9965.EPI-06-0934
16. Fine JD, Bruckner-Tuderman L, Eady RA et al. (2014) Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classification. J Am Acad Dermatol 1–24. doi: 10.1016/j.jaad.2014.01.903
17. Fois G, Weimer M, Busch T et al (2013) Effects of keratin phosphorylation on the mechanical properties of keratin filaments in living cells. FASEB J 27:1322–9. doi:10.1096/fj.12-215632
18. Fu T, Leachman SA, Wilson NJ et al (2011) Genotype-phenotype correlations among pachyonychia congenita patients with K16 mutations. J Invest Dermatol 131:1025–8. doi:10.1038/jid.2010.373
19. Fu DJ, Thomson C, Lunny DP et al (2014) Keratin 9 is required for the structural integrity and terminal differentiation of the palmoplantar epidermis. J Invest Dermatol 134:754–63. doi:10.1038/jid.2013.356
20. Gutierrez JA, Hannoush ZC, Vargas LG et al (2013) A novel non-sense mutation in keratin 10 causes a familial case of recessive epidermolytic ichthyosis. Mol Genet Genomic Med 1:108–112. doi:10.1002/mgg3.6
21. Irvine AD, McLean WH (1999) Human keratin diseases: the increasing spectrum of disease and subtlety of the phenotype-genotype correlation. Br J Dermatol 140:815–28
22. Karantza V (2011) Keratins in health and cancer: more than mere epithelial cell markers. Oncogene 30:127–38. doi:10.1038/onc.2010.456
23. Kerns M, DePianto D, Yamamoto M, Coulombe PA (2010) Differential modulation of keratin expression by sulforaphane occurs via Nrf2-dependent and -independent pathways in skin epithelia. Mol Biol Cell 21:4068–75. doi:10.1091/mbc.E10-02-0153
24. Ku N-O, Toivola DM, Strnad P, Omary MB (2010) Cytoskeletal keratin glycosylation protects epithelial tissue from injury. Nat Cell Biol 12:876–85. doi:10.1038/ncb2091
25. Lane EB, McLean WHI (2004) Keratins and skin disorders. J Pathol 204:355–66. doi:10.1002/path.1643
26. Lane EB, Rugg EL, Navsaria H et al (1992) A mutation in the conserved helix termination peptide of keratin 5 in hereditary skin blistering. Nature 356:244–6. doi:10.1038/356244a0
27. Leachman SA, Hickerson RP, Schwartz ME et al (2010) First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorder. Mol Ther 18:442–6. doi:10.1038/mt.2009.273
28. Lessard JC, Coulombe PA (2012) Keratin 16-null mice develop palmoplantar keratoderma, a hallmark feature of pachyonychia congenita and related disorders. J Invest Dermatol 132:1384–91. doi:10.1038/jid.2012.6
29. Lessard JC, Piña-Paz S, Rotty JD et al (2013) Keratin 16 regulates innate immunity in response to epidermal barrier breach. Proc Natl Acad Sci U S A 110:19537–42. doi:10.1073/pnas.1309576110
30. Lettner T, Lang R, Klausegger A et al (2013) MMP-9 and CXCL8/IL-8 are potential therapeutic targets in epidermolysis bullosa simplex. PLoS ONE 8:e70123. doi:10.1371/journal.pone.0070123
31. McLean WHI, Moore CBT (2011) Keratin disorders: from gene to therapy. Hum Mol Genet 20:R189–97. doi:10.1093/hmg/ddr379
32. McLean WHI, Hansen CD, Eliason MJ, Smith FJD (2011) The phenotypic and molecular genetic features of pachyonychia congenita. J Invest Dermatol 131:1015–7. doi:10.1038/jid.2011.59
33. Oji V, Tadini G, Akiyama M et al (2010) Revised nomenclature and classification of inherited ichthyoses: results of the first ichthyosis consensus conference in Sorèze 2009. J Am Acad Dermatol 63:607–41. doi:10.1016/j.jaad.2009.11.020, Review
34. O'Toole EA, Kaspar RL, Sprecher E et al (2014) Pachyonychia congenita cornered: report on the 11th annual international pachyonychia congenita consortium meeting. Br J Dermatol. doi:10.1111/bjd.13341
35. Pan X, Hobbs RP, Coulombe PA (2013) The expanding significance of keratin intermediate filaments in normal and diseased epithelia. Curr Opin Cell Biol 25:47–56. doi:10.1016/j.ceb.2012.10.018
36. Pedrioli LMD, Fu DJ et al (2012) Generic and personalized RNAi-based therapeutics for a dominant-negative epidermal fragility disorder. J Invest Dermatol 132:1627–35. doi:10.1038/jid.2012.28
37. Ramot Y, Sugawara K, Zákány N et al (2013) A novel control of human keratin expression: cannabinoid receptor 1-mediated signaling down-regulates the expression of keratins K6 and K16 in human keratinocytes in vitro and in situ. Peer J 1:e40. doi:10.7717/peerj.40
38. Roth W, Reuter U, Wohlenberg C et al (2009) Cytokines as genetic modifiers in K5−/− mice and in human epidermolysis bullosa simplex. Hum Mutat 30:832–41. doi:10.1002/humu.20981
39. Schweizer J, Bowden PE, Coulombe PA et al (2006) New consensus nomenclature for mammalian keratins. J Cell Biol 174:169–74. doi:10.1083/jcb.200603161
40. Shimomura Y (2012) Congenital hair loss disorders: rare, but not too rare. J Dermatol 39:3–10. doi:10.1111/j.1346-8138.2011.01395.x
41. Smith F (2003) The molecular genetics of keratin disorders. Am J Clin Dermatol 4:347–64
42. Snider NT, Omary MB (2014) Post-translational modifications of intermediate filament proteins: mechanisms and functions. Nat Rev Mol Cell Biol 15:163–77. doi:10.1038/nrm3753
43. Stacey SN, Sulem P, Masson G et al (2009) New common variants affecting susceptibility to basal cell carcinoma. Nat Genet 41:909–14. doi:10.1038/ng.412
44. Steinert PM (1990) The two-chain coiled-coil molecule of native epidermal keratin intermediate filaments is a type I-type II heterodimer. J Biol Chem 265:8766–74
45. Szeverenyi I, Cassidy AJ, Chung CW et al (2008) The human intermediate filament database: comprehensive information on a gene family involved in many human diseases. Hum Mutat 29:351–60. doi:10.1002/humu.20652
46. Wally V, Kitzmueller S, Lagler F et al (2013) Topical diacerein for epidermolysis bullosa: a randomized controlled pilot study. Orphanet J Rare Dis 8:69. doi:10.1186/1750-1172-8-69
47. Weber K, Geisler N (1985) Intermediate filaments: structural conservation and divergence. Ann N Y Acad Sci 455:126–43
48. Wilson NJ, O'Toole EA, Milstone LM et al (2014) The molecular genetic analysis of the expanding pachyonychia congenita case collection. Br J Dermatol 171:343–55. doi:10.1111/bjd.12958
49. Zhao Y, Gartner U, Smith FJD, McLean WHI (2011) Statins downregulate K6a promoter activity: a possible therapeutic avenue for pachyonychia congenita. J Invest Dermatol 131:1045–52. doi:10.1038/jid.2011.41